| | | | | | | | | | |
|
| |
|
| Dockets
Entered On February 23, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2004M-0064
|
| P030005 - CONTAK RENEWAL TR Models H125 and H120 with the Model 2865 Version 1.8 Application Software
|
|
|
|
|
| 2004P-0059
|
| Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
|
|
|
|
|
| 2004P-0075
|
| Prohibit the marketing and distribution of Authorized Generics until the expiraration of the first generic applicant's exclusivity period.
|
|
| |
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
| NSA
1
|
| FDA
|
| Vol #:
|
| 8
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
12800
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12801
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12802
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12803
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12804
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12805
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12806
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12807
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12808
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12809
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12810
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12811
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12812
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12813
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12814
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12815
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12816
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12817
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12818
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12819
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12820
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12821
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12822
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12823
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12824
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12825
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
| | | | | | | | |
|
|
|
|
| LET
12826
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12827
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12828
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12829
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12830
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12831
|
| NOW Foods
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12832
|
| NOW Foods
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12833
|
| Qualiceutix Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12834
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12835
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
|
|
|
| LET
12836
|
| NBTY Inc.
|
| Vol #:
|
| 104
|
|
| |
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| EMC 5773
|
| Tona Monroe
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5774
|
| Kristeen Gillooly
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5775
|
| Kristeen Gillooly
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5776
|
| Emily Strobaugh
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5777
|
| Diane Galion
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5778
|
| Lauren Verruni
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5779
|
| Rae Stang
|
| Vol #:
|
| 789
|
|
| |
|
| 2004M-0064
|
| P030005 - CONTAK RENEWAL TR Models H125 and H120 with the Model 2865 Version 1.8 Application Software
|
|
|
|
|
| AAV
1
|
| Guidant Corporation
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0059
|
| Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
|
|
|
|
|
| ACK
1
|
| HFS-830 to Emord and Associates PC
|
| Vol #:
|
| 13
|
|
|
|
|
| CP
1
|
| Weider Nurition International Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| LET
1
|
| Weider Nutrition International Inc & FDA
|
| Vol #:
|
| 13
|
|
|
|
|
| LET
2
|
| Emord & Associates PC
|
| Vol #:
|
| 13
|
|
|
|
|
| LET
3
|
| HFS-4 to Emord & Associates PC
|
| Vol #:
|
| 13
|
|
|
|
|
| MM
1
|
| FDA & Emord & Associates, Weider Nutritioin, Michigan State University
|
| Vol #:
|
| 13
|
|
|
|
|
| PDN
1
Attachments
|
| HFS-4 to Emord & Associates, PC
|
| Vol #:
|
| 14
|
|
|
|
|
| SUP
1
|
| Weider Nutrition International Inc
|
| Vol #:
|
| 13
|
|
|
|
|
| SUP
2
Reference
|
| Weider Nutrition International Inc
|
| Vol #:
|
| 13
|
|
|
|
|
| SUP
3
|
| Emord & Associates, PC
|
| Vol #:
|
| 13
|
|
|
|
|
| SUP
4
CV, References
|
| Weider Nutrition
|
| Vol #:
|
| 15
|
|
|
|
|
| 2004P-0075
|
| Prohibit the marketing and distribution of Authorized Generics until the expiraration of the first generic applicant's exclusivity period.
|
|
